FATE THERAPEUTICS INC (30) | License Agreements (6)
Recent Contracts
-
License Agreement, dated April 9, 2020, by and between the Registrant and Dana-Farber Cancer Institute, Inc
(Filed With SEC on February 28, 2022)
-
Whitehead Institute for Biomedical Research Exclusive Patent License Agreement between the Registrant and the Whitehead Institute for Biomedical Research, dated as of February 24,...
(Filed With SEC on February 24, 2021)
-
License Agreement between the Registrant and The Scripps Research Institute, dated as of July 13, 2009
(Filed With SEC on February 24, 2021)
-
License Agreement between the Registrant and The Scripps Research Institute, dated as of May 25, 2010
(Filed With SEC on February 24, 2021)
-
License Agreement between the Registrant and The Scripps Research Institute, dated as of August 24, 2010
(Filed With SEC on February 24, 2021)
-
Patent License Agreement by and between the Registrant and Max-Delbrck-Centrum fr Molekulare Medizin in der Helmholtz-Gemeinschaft, dated August 30, 2019
(Filed With SEC on February 24, 2021)
